US 10023637
Combination immunotherapy for the treatment of cancer
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10023637 (Combination immunotherapy for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/1709, A61K39/3955